Pharma News, 2024

Valneva has announced that its single-dose vaccine, Ixchiq, has been recommended by the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) ...

The popular weight-loss drug, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who ...

Eli Lilly said that the Food and Drug Administration has pushed back its approval decision deadline for the drugmaker’s experimental Alzheimer’s treatment donanemab in a surprise move.

Integrating Ambrx's ADC technology into J&J's portfolio will aid in advancing the development of targeted oncology therapies. Johnson & Johnson (J&J) has concluded the acquisition of c...

The company says it will pause promotion of the drug, Relyvrio (sodium phenylbutyrate plus taurursodiol), and may pull it from the market in the coming weeks.

The investment will also help to enhance public health protection and pandemic preparedness in the UK.

NodThera, a leading clinical-stage biotech developing brain-penetrant NLRP3 inflammasome inhibitors to treat chronic inflammatory diseases, today announces positive data from its Phase Ib/IIa stud...

Apparently, C4 Therapeutics' protein degradation tech brings all the Mercks to the yard. The Massachusetts biotech has signed on Merck KGaA in a $740 million biobucks partnership to find two...

In partnership between Imperial College London (ICL) and Imperial College Healthcare NHS Trust (ICHNT), the international Mobilize trial has issued first doses of Moderna’s experimental mRNA the...

Among patients with idiopathic pulmonary fibrosis, lung function decline was comparable between 52-week zinpentraxin alfa treatment and placebo, according to results published in American Journal ...

For Rare Disease Day, several panels organised by the FDA discussed the importance overcoming accessibility barriers during drug development.

RSV infections account for up to 160,000 hospitalisations among older adults each year in the US.